JPRN-UMIN000029504尚未招募2 期
Balloon occluded transarterial chemoembolization using miriplatin in HCC: A Multicenter, Clinical Phase II study - B-TACE study
The Japanese Society for Transcatheter Hepatic Arterial Embolization0 个研究点目标入组 52 人开始时间: 2017年10月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Bile duct injury(bile duct dilatation), reconstruction of the biliary tract history, history of endoscopic biliary treatment 2) Severe arterio-portal shunting 3) Severe arterial stenosis or obstruction in CECT or AAG 4) Severe ascites or pleural effusion 5) Major portal invation (Vp3 or Vp4) 6) Severe complication (cardiac failure, arrhythmia, angina pectoris, myocardial infarction within 6 months, double cancer, active infection, gastrointestinal bleeding, severe hepatic encephalopathy, severe allergya for contrast media or medicine) 7) Pregnant, nursing or possible pregnant woman 8) Qualified ineligible patients being this clinical trial by responsible doctor
研究者
相似试验
招募中
2 期
RAIB-TACE for Hepatocellular Carcinoma refractory or intolerant to Atezolizumab plus BevacizumabHepatocellular Carcinoma, atezolizumab, bevacizumab, TACED006528Hepatocellular CarcinomaJPRN-jRCTs031210114Hasegawa Naoyuki19
已完成
2 期
RAIB-TACE for the Patients with Hepatocellular Carcinoma beyond Up-to 7 CriteriaHepatocellular CarcinomaJPRN-jRCTs031200334Hoshiai Sodai19
进行中（未招募）
不适用
DEBDOX for liver metastases in breast carcinomaEUCTR2012-000973-22-NL
尚未招募
2 期
Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for the Treatment of Metastatic Breast Cancer to the Liver: a pilot studyliver metastases breast cancer10027476NL-OMON37702Antoni van Leeuwenhoek Ziekenhuis10
招募中
不适用
TRENDY trialPatients diagnosed with HCC, Child-Pugh grade A, one tumor 𕟮cm, and 󖾆 years old.NL-OMON28819Erasmus MCDepartment of Radiotherapy100